• Pentoxifylline in Macrophage Inflammation Research

  2026-08-13

  Pentoxifylline provides a practical way to connect phosphodiesterase inhibition with cAMP elevation, nitric oxide suppression, and macrophage-state changes. This guide translates a landmark macrophage study into reproducible workflows for inflammation, psoriasis, and translational immune-model research, with concentration selection and troubleshooting built in.

• Ruxolitinib in Immune Profiling Workflows

  2026-08-13

  Ruxolitinib (INCB018424) provides a focused way to perturb JAK1/2 signaling while measuring tumor-cell growth and immune-state changes. This workflow translates a high-dimensional murine sarcoma study into practical guidance for progenitor assays, oncogenic JAK2 models, spectral cytometry, and combination-therapy experiments.

• Methylprednisolone Sodium Succinate Research Workflows

  2026-08-12

  Build more reproducible inflammation, leukocyte-function, and apoptosis assays with a concentration-aware workflow for Methylprednisolone Sodium Succinate. The guide separates literature-supported observations from practical starting conditions and shows how receptor-focused time-course design can improve translational interpretation.

• Baicalin Methyl Ester: From Barrier Biology to Translation

  2026-08-12

  Baicalin methyl ester is an esterified derivative of baicalin with evidence for protecting epithelial tight-junction architecture in LPS-induced intestinal barrier damage models. This perspective translates the P65/TNF-α/MLCK/ZO-1 findings into practical assay design, product-selection guidance, and a disciplined path toward human-relevant validation.

• Entecavir Workflows for HBV Replication Studies

  2026-08-11

  Build reproducible HBV suppression assays around Entecavir, from DMSO stock preparation through polymerase, viral-DNA, and cccDNA readouts. Its low-nanomolar benchmark activity and performance against lamivudine-resistant variants make BMS200475 valuable for screening validation and translational assay calibration.

• N-octanoyl-L-Homoserine lactone: From Signal to Strategy

  2026-08-11

  N-octanoyl-L-Homoserine lactone, or C8-HSL, is moving from a bacterial communication tool toward a translational probe for host–microbe biology. This article connects quorum-sensing mechanism, lung-cancer evidence, experimental design, and strategic opportunities in microbial pathogenicity research.

• Time-Resolved Protein Synthesis Maps Signaling Phases

  2026-08-10

  Lee and Muir developed a proximity-triggered protein trans-splicing platform that assembles intracellular proteins from pre-made parts with temporal control. Applying the system to BCR-ABL and DNAJ-PKAc oncofusions revealed distinct phosphorylation phases and exposed signaling components that may connect fusion-protein activity to cancer-cell transformation.

• SLC25A1, Senescence, and Cisplatin Resistance in HNSCC

  2026-08-09

  A 2026 npj Precision Oncology study identifies SLC25A1 as a metabolic and epigenetic regulator of cisplatin resistance in head and neck squamous cell carcinoma. Its findings connect mitochondrial citrate transport, cytosolic acetyl-CoA, H3K27ac-dependent transcription, and cellular senescence, while positioning SLC25A1 inhibition as a possible strategy for resistant disease.

• Lenalidomide and DOT1L: Reprogramming Myeloma Immunity

  2026-08-08

  Lenalidomide and CC-5013 are examined through a new epigenetic–innate immune lens for multiple myeloma research. This article translates DOT1L, STING, interferon-response, and IRF4–MYC findings into practical assay decisions and better-controlled experimental workflows.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-08-07

  Build sensitive, reproducible immunodetection workflows for goat primary antibodies across western blotting, ELISA, dot blot, ICC/IF, and tissue staining. This guide translates findings from localized p21 mRNA–LNP bladder cancer research into practical assay choices, controls, and troubleshooting strategies.

• Recombinant Human FGF-19: Precision Tools for Metabolic Assa

  2026-08-07

  Explore the advanced scientific and practical foundations of Recombinant Human FGF-19 in metabolic regulation research. This article delivers unique assay design insights, protocol optimization, and translational perspectives for endocrine and renal applications.

• 1-Phenyl-2-Pentanol from Moringa: Anti-Fibrotic Effects in H

  2026-08-06

  This study demonstrates that 1-phenyl-2-pentanol, isolated from Moringa oleifera, attenuates hepatic stellate cell activation and fibrosis signaling in vitro. Through transcriptomic, proteomic, and functional assays, the research uncovers Wnt/β-catenin and TGF-β1 pathway modulation as key mechanisms, suggesting new anti-fibrotic targets for liver disease models.

• HOXC8 Suppresses Pyroptosis by Inhibiting Caspase-1 in NSCLC

  2026-08-06

  This study uncovers how HOXC8 restricts pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by downregulating caspase-1 transcription via HDAC1/2 recruitment. These findings illuminate an epigenetic mechanism linking HOXC8 to tumor survival and suggest new strategies for targeting cell death pathways in lung cancer.

• Entecavir (BMS200475): Optimizing HBV Replication Inhibition

  2026-08-05

  Entecavir stands as a benchmark for chronic hepatitis B virus replication inhibition, offering high potency even in lamivudine-resistant strains. This guide translates reference-backed findings into actionable protocols, troubleshooting tips, and comparative insights for researchers seeking robust and reproducible HBV studies.

• Spectral Cytometry Unveils Ruxolitinib–oHSV Immune Modulatio

  2026-08-05

  This study pioneers a 46-parameter spectral flow cytometry approach to dissect immune cell dynamics in murine sarcoma treated with Ruxolitinib and oncolytic HSV. The findings reveal heightened CD4 T cell and germinal center B cell activity, offering deeper insight into combinatorial immunotherapy and high-dimensional immune profiling workflows.

16181 records 1/1079 page Next 12345 下5页 Last page